Skip to main content
. 2023 Aug 30;11(9):2424. doi: 10.3390/biomedicines11092424
ACT Asthma Control Test
BMI Body mass index
CRSwNP Chronic Rhinosinusitis with nasal polyps
FeNO Fractional exhaled nitric oxide
FEV1 Forced expiratory volume 1 s
Ig Immunoglobulin
IL Interleukin
MEP Mepolizumab
OCS Oral Corticosteroids
MCID Minimal clinically important difference
RCT Randomized controlled trials
RL Real Life
SANI Severe Asthma Network Italy
SNOT-22 Sinonasal Outcome Test
T2 Type 2